This compound is a bis-protected imidazole-containing intermediate featuring two pyrrolidine rings each bearing a tert-butoxycarbonyl (Boc) protecting group. It is primarily utilized in the synthesis of compounds for hepatitis C virus (HCV) research.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1007882-23-6
3-(4-Methoxy-phenoxy)-propylamine
pharmaceutical intermediate
4-chloro-2-methoxypyridine-3-carbaldehyde
pharmaceutical intermediate
2-Methoxy-4-methylpyridine
pharmaceutical intermediate
(S,Z)-(2-(5-((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethyl)diphenylphosphine oxide
Pharmaceutical intermediate for organic synthesis
Daklatasvir
active pharmaceutical ingredient
Daclatasvir dihydrochloride
active pharmaceutical ingredient
2-((2S)-Pyrrolidin-2-yl)-5-(4-(4-(2-((2S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)phenyl)-1himidazole tetrahydrochloride
pharmaceutical intermediate
tert-butyl (2S)-2-[5-[4-[4-[2-[(2S)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylate
WPMTYMFNINZZHE-KYJUHHDHSA-N
CC(C)(C)OC(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)OC(C)(C)C